Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Fate Therapeutics Inc
F6TCurrent price
2.3 EUR
-0.081 EUR (-3.40%)
Last closed
2.34 EUR
Company
–
ISIN
US31189P1021
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
268 533 568 EUR
Yield for 12 month
+0.66 %
1Y
3Y
5Y
10Y
15Y
F6T
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma, and FT522, to treat lymphoma and autoimmune disorders. Its CAR T-cell programs include FT819 to treat hematologic malignancies and solid tumors, and FT825 to treat solid tumors. The company has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of cancer. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California. Address: 12278 Scripps Summit Drive, San Diego, CA, United States, 92131
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
103.85 EURP/E ratio
–Dividend Yield
–Current Year
+60 071 404 EUR
Last Year
+91 053 095 EUR
Current Quarter
+6 403 028 EUR
Last Quarter
+1 820 116 EUR
Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Key Figures F6T
1 year
3 years
5 years
10 years
EBITDA
-164 700 890 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.5 %
PEG Ratio
–
Return On Equity TTM
-42.1 %
Wall Street Target Price
103.85 EUR
Revenue TTM
12 412 174 EUR
Book Value
3.51 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
625.8 %
Dividend Yield
–
Gross Profit TTM
-225 886 044 EUR
Earnings per share
-1.58 EUR
Diluted Eps TTM
-1.58 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics F6T
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History F6T
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation F6T
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
5.7401
Price Sales TTM
21.6347
Enterprise Value EBITDA
-2.4144
Price Book MRQ
0.7246
Financials F6T
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators F6T
For 52 weeks
1.86 EUR
7.64 EUR
50 Day MA
2.98 EUR
Shares Short Prior Month
–
200 Day MA
4.22 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart